Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guided Therapeutics (GTHP) Inventory Average (2016 - 2025)

Guided Therapeutics' Inventory Average history spans 14 years, with the latest figure at $589000.0 for Q3 2025.

  • For Q3 2025, Inventory Average fell 7.1% year-over-year to $589000.0; the TTM value through Sep 2025 reached $589000.0, down 7.1%, while the annual FY2024 figure was $632500.0, 7.2% up from the prior year.
  • Inventory Average for Q3 2025 was $589000.0 at Guided Therapeutics, down from $614000.0 in the prior quarter.
  • Across five years, Inventory Average topped out at $640000.0 in Q4 2023 and bottomed at $566500.0 in Q1 2023.
  • The 5-year median for Inventory Average is $610500.0 (2021), against an average of $603894.7.
  • The largest annual shift saw Inventory Average soared 1074.04% in 2021 before it fell 7.92% in 2022.
  • A 5-year view of Inventory Average shows it stood at $580500.0 in 2021, then decreased by 1.46% to $572000.0 in 2022, then grew by 11.89% to $640000.0 in 2023, then fell by 0.86% to $634500.0 in 2024, then fell by 7.17% to $589000.0 in 2025.
  • Per Business Quant, the three most recent readings for GTHP's Inventory Average are $589000.0 (Q3 2025), $614000.0 (Q2 2025), and $633000.0 (Q1 2025).